Peer Review History
| Original SubmissionAugust 2, 2021 |
|---|
|
PONE-D-21-24921Exploring hospital readiness for implementing the National TB infection control guidelines in two public tertiary care hospitals, BangladeshPLOS ONE Dear Dr. Islam, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rabia Hussain Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files" 4. Thank you for stating the following in the Acknowledgments / Financial Support Section of your manuscript: This research protocol was funded by the United States Centre for Disease Control and Prevention (CDC) through the cooperative agreement grant number 5U01GH1207. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding This research protocol was funded by the United States Centre for Disease Control and Prevention (CDC) through the cooperative agreement grant number 5U01GH1207. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 6. We note that you have referenced (ie. Bewick et al. [5]) which has currently not yet been accepted for publication. Please remove this from your References and amend this to state in the body of your manuscript: (ie “Bewick et al. [Unpublished]”) as detailed online in our guide for authors http://journals.plos.org/plosone/s/submission-guidelines#loc-reference-style [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: General comments This manuscript has addressed an important aspect about Tuberculosis Infections Prevention and Control at hospital settings in a high TB burden country-Bangladesh. The authors used multiple methodological approach (Triangulation) to collect rich data/information hence presented a reliable findings. The authors used a rigorous analysis and results and discussion sections were logically narrated. On the other hand, the author did not insert lines in the manuscript for easy review. Please amend this in the next review. Specific comments Title: The title lacks methodological design and the word "hospital" is repeated. I suggest the title reads: Full title: Readiness of tertiary care hospitals to implement the National TB infection prevention and control guidelines in Bangladesh: A qualitative exploration Short title: A qualitative exploration of readiness of hospitals to implement Tuberculosis guidelines Abstract: - The abstract contains many but necessary abbreviations! If it is possible the authors should minimize the number of abbreviations. Others: - The authors should add a paragraph to explain how is TB specialized hospital differs from tertiary hospital. Does TB specialized hospital implement the National TB IPC guideline? - On page 16: A sentence "This situation has probably been exacerbated due to the COVID-19 pandemic, with resources being diverted towards pandemic management". This study was conducted from January to December 2019 before the COVID-19 pandemic. Therefore, the author should consider omitting the sentence. - On page 19: a sentence - All coughing patients should wear a mask "until they confirm the diagnosis". Since the aim is to prevent TB infection, I suggest the author to rephrase the later part of the sentence. It should read "throughout while in hospital or until TB disease is ruled out as well other contagious respiratory infections". Reviewer #2: Since the National Tuberculosis Policy is there in country since long , readiness is not a suitable word , instead authors could have used the phrase bottlenecks in implementation of Latest NTP IPC and highlight the lacunas as per the guidelines . In the abstract"However, there has been a failure to date to assess" needs to be rephrased . Also in main manuscript there are sections which needs better rephrasing. In the reference section ref number 1 and 7 are not published , until they are visible online how can they be cited . Other details have been incorporated in the pdf attached under comments . Reviewer #3: Islam et al have used a qualitative study design to explore hospital readiness for national TB infection control in two public hospitals in Bangladesh. They used a review of national TB infection control policies, key-informant interviews and four focus group discussions with HCWs to understand knowledge,attitude, and practice of TB IPC measures. They found a lack of preparedness, resources, training, and knowledge about TB IPPC practices including of national IPC guidelines in both hospitals. They highlight several factors that limit the ability to implement an infection control program, including overcrowding in wards, built environment and limited IPC resources. They provide suggestions on what steps need to be taken to facilitate implementation of IPC programs. General comments: This paper explores an underappreciated aspect of TB control and highlight important issues that need to be addressed. The methodology is reliable to answer the questions being asked in this study, although the selection participants selected for further interviews appears to be quite arbitrary, especially with the use of seniority as a proxy for expertise. There is a blurring between issues that are unique to TB infection control and those that affect clinical care in general (resource shortage and electronic medical records). The paper would benefit from highlighting gaps and overalps between concerns identified by the study participants and priorities identified by the WHO. It would be helpful to discuss issues of TB IPC unique to outpatient clinics and those unique to the inpatient wards. The discussion needs to be shorter and focused on highlighting the findings from their study and contextualizing them with TB control in Bangladesh. I would strongly recommend against making policy proposals in the discussion as that was not the focus of the study, and because those policies already exist. Specific comments: Introduction Reference 3 appears to be a self-citation of a study done in the same 2 hospitals. Are there additional studies highlighting rates of latent TB infection in other hospitals in Bangladesh? Could those be included as well? Materials and methods: How many participants were screened for interview before arriving at the 51 who were included in the study? Results There is a mention of frequent training that some doctors received - how is that those doctors were not aware of the national TB IPC policy, and why were the doctors unable to use their training to implement infection control activities? Do the public hospitals have dedicated TB wards and clinics? Is there a reason that TB patients are located in all the wards. The limitations on ventilation imposed by overcrowding as well as by hot and cold weather are common in public hospitals across LMIC nations worldwide and raise important issues that need to be addressed. This should be highlighted in the discussion as this is often underestimated by policy makers. Discussion: The discussion needs significant rewriting. The authors should outline their findings which are perceptions and opinions of the participants. It appears that the authors have used those findings to make suggestions about changes that need to be implemented (financing, laboratory services, delays in diagnosis, need for EMR systems) that are not unique to TB. Using the participants opinions to frame policy is unwise, esepecially since the participants have clearly stated they are unaware of the national TB IPC program that likely addresses these issues. Some of the recommendations are quite generic ( improving communication) and speculative. It would be best not to use the discussion to make policy recommendations. The focus of the discussion should be on TB IPC policy in Bangladesh. Can the authors use their findings to identify priorities and a roadmap for implementation of a TB IPC program in public hospitals in Bangladesh? Are their unique aspect that have been identified that are not mentioned in the national policy? Could the authors discuss IPC practices in TB specialty hospitals in Bangladesh and how that compares with public hospitals? There is a mention of frequent training that some doctors received - how is that those doctors were not aware of the national TB IPC policy, and why were the doctors unable to use their training to implement infection control activities? Is the issue a lack of planning or a lack of execution? The authors highlight the cognitive dissonance common in LMICs where HCWs do not wear masks despite being exposed to TB and having high rates of latent TB and active TB. They also have to deal with the stigma that forces them to hide their diagnosis from their colleagues, including working while possibly infectious and contributing to the spread of TB. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Festo K. Shayo Reviewer #2: Yes: Rishabh Kumar Rana Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Preparedness of tertiary care hospitals to implement the National TB infection prevention and control guidelines in Bangladesh: A qualitative exploration PONE-D-21-24921R1 Dear Dr.Islam, I am pleased to inform you that your manuscript is accepted for publication in PLOS One. In your attempt to answer all the questions raised by the reviewers, you have revised your manuscript appropriately. Kind regards, Rabia Hussain Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-24921R1 Preparedness of tertiary care hospitals to implement the National TB infection prevention and control guidelines in Bangladesh: A qualitative exploration Dear Dr. Islam: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Rabia Hussain Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .